An Insertion Variant in CRH Confers an Increased Risk of Central Serous Chorioretinopathy

En-Zhong Jin,Tian-Qi Li,Chi Ren,Li Zhu,Wei Du,Jin-Feng Qu,Yu-Ou Yao,Xiao-Xin Li,Peng Zhou,Lv-Zhen Huang,Ming-Wei Zhao
DOI: https://doi.org/10.1167/iovs.63.9.9
2022-01-01
Abstract:PURPOSE. To identify a novel corticotropin-releasing hormone (CRH) gene variant relevant in patients with central serous chorioretinopathy (CSC). METHODS. We performed a genetic study of CSC in families and sporadic cases with controls. Using whole-exome sequencing and linkage analysis, we identified a heterozygous insertion variant, Gln52insPro, in the CRH gene that cosegregated in two Chinese families with CSC. This variant was evaluated among an additional 1307 patients with CSC and 1438 ethnicity-matched control individuals from three independent Chinese cohorts. RESULTS. The CRH variant was strongly associated with CSC in these cohorts of Chinese patients (P-meta = 1.24 & times; 10 & minus;(11); odds ratio, 3.01; 95% confidence interval, 2.15 & ndash;4.21). The risk variant Gln52insPro decreased CRH gene expression. CONCLUSIONS. Our results implicate the hypothalamic & ndash;pituitary & ndash;adrenal stress response system in the pathogenesis of CSC and provide a novel rationale for therapeutic intervention.
What problem does this paper attempt to address?